BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 20070483)

  • 41. Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.
    Kuivanen T; Tanskanen M; Jahkola T; Impola U; Asko-Seljavaara S; Saarialho-Kere U
    J Cutan Pathol; 2004 Aug; 31(7):483-91. PubMed ID: 15239678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.
    Kang HG; Kim HS; Kim KJ; Oh JH; Lee MR; Seol SM; Han I
    J Orthop Res; 2007 May; 25(5):696-702. PubMed ID: 17262820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invasiveness and MMP expression in pancreatic carcinoma.
    Yang X; Staren ED; Howard JM; Iwamura T; Bartsch JE; Appert HE
    J Surg Res; 2001 Jun; 98(1):33-9. PubMed ID: 11368535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RECK overexpression reduces invasive ability in ameloblastoma cells.
    Liang QX; Liang YC; Xu ZY; Chen WL; Xie HL; Zhang B
    J Oral Pathol Med; 2014 Sep; 43(8):613-8. PubMed ID: 24646032
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
    Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced expression of podoplanin in ameloblastomas.
    González-Alva P; Tanaka A; Oku Y; Miyazaki Y; Okamoto E; Fujinami M; Yoshida N; Kikuchi K; Ide F; Sakashita H; Kusama K
    J Oral Pathol Med; 2010 Jan; 39(1):103-9. PubMed ID: 19691459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Basaloid squamous carcinoma of the oral cavity: report of 2 cases and study of AgNOR, PCNA, p53, and MMP expression.
    Coletta RD; Cotrim P; Vargas PA; Villalba H; Pires FR; de Moraes M; de Almeida OP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):563-9. PubMed ID: 11346736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
    He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS
    Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
    Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SPARC mRNA expression as a prognostic marker for pancreatic adenocarcinoma patients.
    Miyoshi K; Sato N; Ohuchida K; Mizumoto K; Tanaka M
    Anticancer Res; 2010 Mar; 30(3):867-71. PubMed ID: 20393008
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.
    Brown TJ; Shaw PA; Karp X; Huynh MH; Begley H; Ringuette MJ
    Gynecol Oncol; 1999 Oct; 75(1):25-33. PubMed ID: 10502421
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
    Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
    J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
    Terada T; Okada Y; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis.
    Määttä M; Soini Y; Liakka A; Autio-Harmainen H
    Clin Cancer Res; 2000 Jul; 6(7):2726-34. PubMed ID: 10914717
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma.
    Zhou X; Tan FK; Reveille JD; Wallis D; Milewicz DM; Ahn C; Wang A; Arnett FC
    Arthritis Rheum; 2002 Nov; 46(11):2990-9. PubMed ID: 12428242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells.
    McClung HM; Thomas SL; Osenkowski P; Toth M; Menon P; Raz A; Fridman R; Rempel SA
    Neurosci Lett; 2007 May; 419(2):172-7. PubMed ID: 17490812
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative analysis of the immunohistochemical expression of collagen IV, MMP-9, and TIMP-2 in odontogenic cysts and tumors.
    Henriques ÁC; Vasconcelos MG; Galvão HC; de Souza LB; de Almeida Freitas R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Oct; 112(4):468-75. PubMed ID: 21911204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical significance of SPARC gene expression in patients with gastric cancer.
    Sato T; Oshima T; Yamamoto N; Yamada T; Hasegawa S; Yukawa N; Numata K; Kunisaki C; Tanaka K; Shiozawa M; Yoshikawa T; Akaike M; Rino Y; Imada T; Masuda M
    J Surg Oncol; 2013 Nov; 108(6):364-8. PubMed ID: 24018911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.